Mostrando 7 resultados de: 7
Subtipo de publicación
Article(7)
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant
ArticleAbstract: Rapid COVID-19 diagnosis in the hospital is essential, although this is complicated by 30%–50% of noPalabras claves:covid-19, D614G, point of care testing, rapid diagnoses, SARS-COV-2Autores:Abeseabe R., Allain J.P., Amoroso G., Assennato S.M., Baker S., Barmpounakis P., Bates A., Bergamaschi L., Bermperi A., Blake E., Bousfield R., Boyle A., Bradley J.R., Briggs J.A.G., Brown N., Bucke A., Bundi P., Calder J., Canna L., Chapman D., Chatterjee K., Chiu E., Ciazynska K.A., Clark S., Collier D.A., Crucusio C., Curran M.D., Davidson F., de Jesus R., Demeris N., Domingo J., Dougan G., Elmer A., Emma Jones, Enoch D., Fabiculana M., Foster E., Frost S., Gkrania-Klotsas E., Goel N., Goodfellow I.G., Gupta R.K., Hardwick S., Hardy R., Harris J., Hewitt S., Hosmillo M., James L.C., Jose S., Kennet J., Kiss L., Knock H., Kourampa E., Kourampa J., Lehner P.J., Lyons P.A., Matheson N.J., Meadows A., Mendoza V., Meng B., Mescia F., Mlcochova P., Mynott L., Nathan J.A., O'Brien C., Overhill A., Palmar S., Pasquale C., Perales M., Phillips D., Price J., Ramenatte N., Rastall R., Ribeiro C., Ritchie A., Rowlands J., Rundell V., Saunders C., Shaw A., Sipple J., Skells R., Smith K.G.C., Sparkes D., Temperton N.J., Tordesillas H., Toshner M., Vallier A.L., Vargas P., Vergese B., Vicente I., Watson L., Weekes M.P., Williams A., Wilson M., Worsley J., Xiong X., Zerrudo J.A., Zhang H.Fuentes:scopusAge-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
ArticleAbstract: Although two-dose mRNA vaccination provides excellent protection against SARS-CoV-2, there is littlePalabras claves:Autores:Abdullahi A., Baker S., Bergamaschi L., Betancourt A., Bower G., Bucke A., Bullman B., Bunclark K., Calder J., Canna L., Collier D.A., Cossetti C., Datir R.P., de Sa A., Domingo J., Dougan G., Dunmore B.J., Eckart E.M., Elmer A., Emma Jones, Epping M., Fawke S., Ferreira I.A.T.M., Fuller S., Gleadall N., Graf S., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Huhn O., Hunter K., Jackson S., Jarvis I., Jose S., Josipovic M., Kennet J., Kingston N., Kotagiri P., Kourampa J., Krishna B., Legchenko E., Lehner P.J., Lewis D., Lim E.Y., Lyons P.A., Mackay M., Marsden J., Martin J., Matara C., Matheson N.J., Maxwell P., Meadows A., Meng B., Mescia F., Michael A., Nice F., Okecha G., Omarjee O., Owehand W.H., O’Brien C., O’Donnell C., Perera M., Pointon L., Pond N., Potts M., Price J., Publico C., Rastall R., Ribeiro C., Richoz N., Romashova V., Rossi S., Rowlands J., Ruffolo V., Saunders C., Sharma R., Shaw A., Shih J., Stefanucci L., Stephens J., Strezlecki M., Summers C., Sutcliffe R., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Toshner M., Touizer E., Treacy C., Turner L., Weekes M.P., Wood J., Wylot M., Yarkoni N.S.Fuentes:scopusSensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
ArticleAbstract: Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is compounded in somePalabras claves:Autores:Baker S., Bassi J., Bergamaschi L., Bernardo M. Gutierrez, Betancourt A., Bianchi S., Bowen J., Bower G., Bucke A., Bullman B., Calder J., Cameroni E., Canna L., Collier D.A., Cossetti C., Culap K., Datir R.P., De Marco A., de Sa A., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Fawke S., Ferreira I.A.T.M., Fuller S., Garzoni C., Graf S., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Huhn O., Hunter K., Jackson S., Jaconi S., Jarvis I., Jose S., Kemp S.A., Kennet J., Kingston N., Kourampa J., Legchenko E., Lehner P.J., Lewis D., Lyons P.A., Marsden J., Martin J., Matara C., Matheson N.J., Meadows A., Meng B., Mescia F., Nice F., Okecha G., Omarjee O., Owehand W.H., O’Brien C., O’Donnell C., Pellanda A.F., Perera M., Pinto D., Pizzuto M.S., Pointon L., Pond N., Price J., Publico C., Rastall R., Ribeiro C., Richoz N., Riva A., Romashova V., Rowlands J., Ruffolo V., Saunders C., Sharma R., Shih J., Silacci-Fregni C., Snell G., Stefanucci L., Stephens J., Strezlecki M., Summers C., Sutcliffe R., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Tortorici M.A., Toshner M., Treacy C., Walls A.C., Weekes M.P., Wood J., Wylot M., Yarkoni N.S.Fuentes:scopusRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
ArticleAbstract: We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple inPalabras claves:Alpha variant, antibody escape, B.1.1.7, covid-19, deletion, infectivity, neutralizing antibodies, RESISTANCE, SARS-COV-2, spike mutationAutores:Aanensen D.M., Aggarwal D., Alderton A., Amato R., Andersson M.I., Ariani C.V., Awan A.R., Barrett J., Bashton M., Bassett A.R., Bernardo M. Gutierrez, Bonsall D., Bucca G., Bull M., Chand M., Chapman M.H.S., Chauhan A.J., Collier D.A., Connor T.R., Constantinidou C., Corden S., Cottrell S., Curran M.D., Darby A.C., Datir R.P., de Silva T.I., Dewar R., Elliott S., Fairley D.J., Ferreira I.A.T.M., Gallo G., Glaysher S., Golubchik T., Goncalves S., Hamilton W.L., Harrison E.M., Harvey W.T., Hassan-Ibrahim M.O., Hiscox J.A., Holden M.T.G., Jackson D.K., Jahun A.S., Jesudason N.G., Johnston I., Kemp S.A., Kwiatkowski D.P., Langford C.F., Lawniczak M., Li K.K., Livett R., Loman N.J., Loose M.W., Loveson K.F., Lowe H., Ludden C., Lytras S., Marelli S., Martincorena I., Martinez Nunez R.T., McCann C.M., McHugh M.P., McKenna J.P., McMurray C., Meng B., Mlcochova P., Mohamed A., Moore C., Moses S., Nelson A., Nicholls S.M., Osman H., O’Grady J., Pacchiarini N., Page A.J., Pandey S., Papa G., Parker M.D., Parmar S., Paterson S., Prieto J.A., Pybus O.G., Rambaut A., Robson S.C., Saeed K., Shah R.N., Shepherd J.G., Sillitoe J., Smith C.P., Smith D.L., Snell L.B., Taha Y., Templeton K.E., Thakur N., Thomson E.C., Torok M.E., Underwood A.P., Unnikrishnan M., Volz E.M., Wang D., Watkins J., Young G.R.Fuentes:scopusSARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
ArticleAbstract: The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was fiPalabras claves:Autores:Abdullahi A., Abraham P., Agarwal M., Albecka A., Asakura H., Bashyam M.D., Bhat M., Biswas N.K., Brown J., Caputo D., Charles O.J., Chattopadhyay P., Chaudhary U., Chauhan H., Cherian S.S., Chiba M., Chinnaswamy S., Collier D.A., Dalal A., Das S., Datir R.P., Datta M., Datta S., Desai A.S., Devi P., Dhar M.S., Dikid T., Emma Jones, Ferreira I.A.T.M., Goel N., Gogia H., Goonawardane N., Ito J., Kabra S., Kawabata R., Kemp S.A., Kimura I., Kosugi Y., Kumar S., Kumari S., Lall H., Madan P., Maitra A., Mani R.S., Manjunatha M.V., Marwal R., Mayor S., Meena N., Mellan T., Meng B., Mishra S., Mlcochova P., Morizako N., Nagashima M., Nandicoori V., Oberoi J.K., Oide A., Palakodeti D., Pandey R., Papa G., Parida A., Pattabiraman C., Peacock T., Pillai A., Ponnusamy K., Potdar V.A., Prasad P., Radhakrishnan V.S., Raghav S.K., Ramakrishnan U., Raveendran R., Sadamasu K., Saito A., Sarin A., Satwik A., Scaria V., Sengupta S., Seshasayee A.S.N., Sharma R., Sharma U., Shouche Y.S., Singh M.K., Singh P., Singh S., Sivasubbu S., Soni N., Sowpati D.T., Suganami M., Tallapaka K.B., Thangaraj K., Udupi G.A., Uriu K., Vaishya R., Verma K., Wattal C., Whittaker C., Yokoyama M., Yoshimura K., Zhou J.Fuentes:scopusSARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity
ArticleAbstract: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike N-terminal domain (NTD) remaiPalabras claves:CP: Microbiology, DELTA, entry, fusogenicity, NTD, Omicron, Organoid, SARS-COV-2, spike, TMPRSS2Autores:Allison J., Baker S., Betancourt A., Bower G., Bucke A., Bullman B., Bunclark K., Butcher H., Calder J., Canna L., Caputo D., Choi J., Clapham-Riley D., Cossetti C., Datir R.P., de Bie E.M.D.D., de Sa A., Dewhurst E., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Fawke S., Fuller S., Furlong A., Gleadall N., Graf S., Graves B., Gray J., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Hunter K., Ivers T., Jackson S., Jarvis I., Jose S., Josipovic M., Kennet J., Kingston N., Kourampa J., Krishna B., Le Gresley E., Legchenko E., Lehner P.J., Linger R., Lyons P.A., Mackay M., Martin J., Matara C., Matheson N.J., Maxwell P., Meadows A., Meloy S., Meng B., Mescia F., Muldoon F., Nice F., O'Brien C., O'Donnell C., Omarjee O., Ovington N., Owehand W.H., Papadia S., Perera M., Phelan I., Pointon L., Potts M., Price J., Publico C., Rastall R., Ribeiro C., Richoz N., Romashova V., Rowlands J., Ruffolo V., Saunders C., Shaw A., Shih J., Stark H., Stefanucci L., Strezlecki M., Summers C., Sutcliffe R., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Toshner M., Treacy C., Turner L., Weekes M.P., Wood J., Wylot M.Fuentes:scopusAltered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
ArticleAbstract: The SARS-CoV-2 Omicron BA.1 variant emerged in 20211 and has multiple mutations in its spike proteinPalabras claves:Autores:Abdullahi A., Baker S., Belén Prado-Vivar, Bernardo M. Gutierrez, Betancourt A., Bower G., Brevini T., Bucke A., Bullman B., Calder J., Canna L., Charles O.J., Cossetti C., de Sa A., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Erika B. Muñoz, Fatihi S., Fawke S., Ferreira I.A.T.M., Fuller S., Gabriel Antonio Trueba Piedrahita , Gerber P.P., Gleadall N., Goonawardane N., Graf S., Grenfell R., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Huang C., Hunter K., Ikeda T., Jackson S., Jarvis I., Jose S., Juan José Guadalupe, Kemp S.A., Kennet J., Kimura I., Kingston N., Kourampa J., Krishna B., Kuramochi J., Legchenko E., Lehner P.J., Lyons P.A., Mallery D.L., Manuel Eduardo Baldeón, Martin J., Matara C., Mateo Caravajal, Matheson N.J., Maxwell P., Meadows A., Meng B., Mescia F., Michelle Grunauer Andrade, Mitsunaga S., Mónica Becerra-Wong, Nice F., Omarjee O., Ouwehand W.H., O’Brien C., O’Donnell C., Papa G., Patricio Rojas-Silva, Paul Andres Cardenas, Paul Cardenas, Perera M., Pointon L., Potts M., Price J., Publico C., Rastall R., Rathore S., Ribeiro C., Richoz N., Romashova V., Rowlands J., Ruffolo V., Saito A., Saunders C., Shaw A., Shih J., Shirakawa K., Stefanucci L., Strezlecki M., Sully Márquez, Summers C., Sutcliffe R., Takaori-Kondo A., Tan T.S., Thaventhiran J.E.D., Tilly T., Tong Z., Tordesillas H., Toshner M., Toyoda M., Treacy C., Turner L., Ueno T., Verónica Barragán, Weekes M.P., Wood J., Wylot M., Yamasoba D., Zepeda S.K.Fuentes:googlescopus